You are here

Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Migraine With or Without Aura
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-78 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- History of at least one typical attack of migraine with or without aura every 6 weeks,
as defined by the International Headache Society (IHS) criteria.

- Capable of taking study medication as outpatients and recording its effects.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnant or breast-feeding women

- Migraine subjects who also suffered from concomitant frequent (non-migraine) headache,
defined as more than six headaches per month on average

- Migraine attacks that were thought to be atypical and had consistently failed to
respond to medical therapy.

NCT01978496
Pfizer
Completed
Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now